Kim Dao

14PUBLICATIONS
37CO-AUTHORS
Toxicology (incl. clinical toxicology)PharmacogenomicsBehavioural epidemiologyInfant and child healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Nov 27, 2025
Janus Kinase Inhibitors During Pregnancy and Adverse Drug Reactions: A Pharmacovigilance Disproportionality Analysis in VigiBase.

Nazanin Abolhassani, Roberta Noseda, Kim Dao

|Oct 31, 2025
Piperacillin dosing in pediatric patients and augmented renal clearance: are current guidelines sufficient to achieve therapeutic concentration coverage?

Anne Ravix, Ermindo Roberto Di Paolo, Kim Dao

|Aug 13, 2025
Population pharmacokinetics of bictegravir in real-world people with HIV.

Pierre Ekobena, Myriam Briki, Kim Dao

|Jan 15, 2025
[Teratovigilance. Antiepileptics during pregnancy and paternal use].

Kim Dao, Léonore Diezi, David Haefliger

|Sep 28, 2024
Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg.

Klervi Golhen, Michael Buettcher, Jörg Huwyler

|Jun 04, 2024
Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study.

R Audran, H Chtioui, A C Thierry

Pageof 3

Frequent Collaborators

5 joint publications

Thierry Buclin

3 joint publications

Ursula Winterfeld

3 joint publications

François R Girardin

2 joint publications

Léonore Diezi